Explore
Validate
Learn
ELISA
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 25006-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- FGFBP1 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated FGFBP1 antibody (Cat. #25006-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IHC,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references A transient transcriptional activation governs unpolarized-to-polarized morphogenesis during embryo implantation.
FGFBP1 as a potential biomarker predicting bacillus Calmette-Guérin response in bladder cancer.
Identification of metastasis-associated exoDEPs in colorectal cancer using label-free proteomics.
Study on the biological mechanism of urolithin a on nasopharyngeal carcinoma in vitro.
Inhibitory effect of the novel tyrosine kinase inhibitor DCC-2036 on triple-negative breast cancer stem cells through AXL-KLF5 positive feedback loop.
Type-2 11β-hydroxysteroid dehydrogenase promotes the metastasis of colorectal cancer via the Fgfbp1-AKT pathway.
Lyu X, Cui Y, Kong Y, Yang M, Shen H, Liao S, Li S, An C, Wang H, Zhang Z, Ong J, Li Y, Du P
Molecular cell 2024 Jul 25;84(14):2665-2681.e13
Molecular cell 2024 Jul 25;84(14):2665-2681.e13
FGFBP1 as a potential biomarker predicting bacillus Calmette-Guérin response in bladder cancer.
Li F, Zhang H, Wang Y, Yao Z, Xie K, Mo Q, Fan Q, Hou L, Deng F, Tan W
Frontiers in immunology 2022;13:954836
Frontiers in immunology 2022;13:954836
Identification of metastasis-associated exoDEPs in colorectal cancer using label-free proteomics.
Liu X, Li N, Zhang C, Wu X, Zhang S, Dong G, Liu G
Translational oncology 2022 May;19:101389
Translational oncology 2022 May;19:101389
Study on the biological mechanism of urolithin a on nasopharyngeal carcinoma in vitro.
Yang Y, Ren ZZ, Wei WJ, He ZL, Deng YL, Wang Z, Fan YC, Zhou J, Jiang LH
Pharmaceutical biology 2022 Dec;60(1):1566-1577
Pharmaceutical biology 2022 Dec;60(1):1566-1577
Inhibitory effect of the novel tyrosine kinase inhibitor DCC-2036 on triple-negative breast cancer stem cells through AXL-KLF5 positive feedback loop.
Shen Y, Zhu Q, Xiao M, Yin L, Feng W, Feng J, He J, Li P, Chen X, Ding W, Zhong J, Zeng Z, Xie Z, Liu J, Zu X
Cell death & disease 2022 Aug 30;13(8):749
Cell death & disease 2022 Aug 30;13(8):749
Type-2 11β-hydroxysteroid dehydrogenase promotes the metastasis of colorectal cancer via the Fgfbp1-AKT pathway.
Chen J, Liu QM, Du PC, Ning D, Mo J, Zhu HD, Wang C, Ge QY, Cheng Q, Zhang XW, Fan YW, Liang HF, Chu L, Chen XP, Zhang BX, Jiang L
American journal of cancer research 2020;10(2):662-673
American journal of cancer research 2020;10(2):662-673
No comments: Submit comment
Supportive validation
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The FGFBP1 antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human FGFBP1. This antibody recognizes human antigen. The FGFBP1 antibody has been validated for the following applications: ELISA, IHC analysis.
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemistry of paraffin-embedded human lung cancer tissue slide using 25006-1-AP( FGFBP1 Antibody) at dilution of 1:50 (under 10x lens)
- Other comments
- IHC
